- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Organic chemistry.
Displaying page 1 of 1.
EudraCT Number: 2012-003090-26 | Sponsor Protocol Number: 110401 | Start Date*: 2013-03-25 |
Sponsor Name:TECNIMEDE ? SOCIEDADE TÉCNICO MEDICINAL S.A. | ||
Full Title: STUDY TO EVALUATE THE PROPORTIONALITY OF 3 ORAL DOSES OF PIRLINDOLE IN HEALTHY VOLUNTEERS. | ||
Medical condition: Not applicable (including healthy volunteers). | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-003035-22 | Sponsor Protocol Number: ACP-103-015 | Start Date*: 2008-11-05 | |||||||||||
Sponsor Name:ACADIA Pharmaceuticals Inc. | |||||||||||||
Full Title: A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson’s Disease | |||||||||||||
Medical condition: Psychosis in Parkinson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) FR (Completed) SE (Completed) BE (Completed) AT (Completed) PT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000790-13 | Sponsor Protocol Number: BIL-0115-MED | Start Date*: 2015-06-10 |
Sponsor Name:FAES FARMA, S.A. | ||
Full Title: A single-centre, randomized, double-blind, crossover, single-dose clinical trial to compare bilastine, desloratadine, rupatadine and placebo in the suppression of wheal and flare induced by intrade... | ||
Medical condition: ALLERGIC RHINOCONJUNTIVITIS AND CHRONIC URTICARIA | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-005475-40 | Sponsor Protocol Number: VP-VEC-162-3502 | Start Date*: 2022-06-08 | |||||||||||
Sponsor Name:Vanda Pharmaceuticals Inc. | |||||||||||||
Full Title: A multicenter, double-blind, randomized study to evaluate the effects of tasimelteon vs. placebo in participants with Delayed Sleep-Wake Phase Disorder (DSWPD) | |||||||||||||
Medical condition: Delayed Sleep-Wake Phase Disorder (DSWPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) AT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
